Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.

作者: Anthony V. D'amico , Clare M. Tempany , Delray Schultz , Robert A. Cormack , Mark Hurwitz

DOI: 10.1016/S0090-4295(03)00772-6

关键词: PSA FailurePerineural invasionMagnetic resonance imagingSurgeryBiopsyProstateProstatectomyMedicineStage (cooking)UrologyBrachytherapy

摘要: Abstract Objectives To determine whether high-dose radiation delivered to a subvolume of the prostate gland (peripheral zone) using intraoperative magnetic resonance imaging-guided brachytherapy provided comparable 5-year prostate-specific antigen (PSA) control rates radical prostatectomy (RP) in select patients compared prospectively but nonrandomized setting. Methods Between 1997 and 2002, 322 196 with clinical Stage T1c, PSA less than 10 ng/mL, biopsy Gleason score 3 + 4 or less, without perineural invasion underwent RP brachytherapy, respectively, had 2-year minimal follow-up. Cox regression multivariable analysis was used evaluate initial therapy, pretreatment level, score, percentage positive biopsies, volume were predictors time post-therapy failure. failure estimated Kaplan-Meier method defined American Society for Therapeutic Radiology Oncology consensus definition. Results Only biopsies ( P = 0.02) significant predictor post-treatment However, distribution this parameter between brachytherapy-treated not significantly different chi-square 0.25). The therapy did predict 0.18). estimate 93% versus 95% log-rank 0.16) patients, respectively. Conclusions Despite only partial prostatic irradiation similar estimates found both RP-managed patients.

参考文章(24)
Nag S, Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations. Seminars in Urologic Oncology. ,vol. 18, pp. 133- 136 ,(2000)
H. R. Withers, Radiation Biology and Treatment Options in Radiation Oncology Cancer Research. ,vol. 59, ,(1999)
Prajnan Das, Ming-H Chen, Kristin Valentine, Lynn Lopes, Robert A Cormack, Andrew A Renshaw, Clare M Tempany, Sanjaya Kumar, Anthony V D’Amico, Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. International Journal of Radiation Oncology Biology Physics. ,vol. 54, pp. 698- 702 ,(2002) , 10.1016/S0360-3016(02)03036-5
Jigna Desai, Richard G. Stock, Nelson N. Stone, Christopher Iannuzzi, J. Keith De Wyngaert, Acute urinary morbidity following I-125 interstitial implantation of the prostate gland Radiation Oncology Investigations. ,vol. 6, pp. 135- 141 ,(1998) , 10.1002/(SICI)1520-6823(1998)6:3<135::AID-ROI4>3.0.CO;2-Z
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
A. T. Porter, J. C. Blasko, P. D. Grimm, S. M. Reddy, H. Ragde, Brachytherapy for Prostate Cancer CA: A Cancer Journal for Clinicians. ,vol. 45, pp. 165- 178 ,(1995) , 10.3322/CANJCLIN.45.3.165
Haakon Ragde, Leroy J. Korb, Abdel-Aziz Elgamal, Gordon L. Grado, Brad S. Nadir, Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer. ,vol. 89, pp. 135- 141 ,(2000) , 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
Michael D Thomas, Robert Cormack, Clare M Tempany, Sanjaya Kumar, Judi Manola, L Schneider, Mark.D Hurwitz, Anthony V D’Amico, Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy International Journal of Radiation Oncology Biology Physics. ,vol. 47, pp. 905- 908 ,(2000) , 10.1016/S0360-3016(00)00541-1
D F Gleason, Histologic Grading and Staging of Prostatic Carcinoma The American Journal of Surgical Pathology. ,vol. 5, pp. 193- ,(1981) , 10.1097/00000478-198103000-00008
William J Catalona, Deborah S Smith, Timothy L Ratliff, Joseph W Basler, Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening JAMA: The Journal of the American Medical Association. ,vol. 270, pp. 948- 954 ,(1993) , 10.1001/JAMA.1993.03510080052031